CAS 9007-34-5

这就是贵公司的产品在自己欧洲网店里的样子
页面、名称、CAS 号、技术信息 —— 都已经就位。
现在只差 5 样,全部与贵公司自己的资料有关。
我们已经做好 产品页面 · 英文名称 · CAS 号 · 技术数据 · 欧盟合规信息框架 需要贵公司提供,只有 5 样 1. 贵公司的商标(logo)
2. 公司名称与注册地址
3. 每种规格的价格
4. 包装规格与最小起订量(25 kg 桶 / 200 L 桶 / 1 t IBC…)
5. 纯度等级(如 99%、AR、GR)
收到这四样之后会发生什么

现在这份安全数据表和产品标签上印的,是 MolGod 的名称和地址。 这是因为贵公司的资料我们还没有 —— 我们不会替贵公司编造。

收到之后,我们把它们全部换成贵公司的
安全数据表、产品标签、产品页面、报价单、发票 —— 从头到尾都是贵公司的品牌, 不会出现我们的名字。

贵公司拿到的是一个可以直接开始卖货的网店,不是一份演示文件。

适用范围:仅限欧盟市场

我们编制的安全数据表依据的是欧盟法规—— (EC) No 1907/2006(REACH)附件 II 及 (EU) 2020/878。

中文版本是从欧盟版本翻译而来的,仅供参考。 它不是中国市场上具有法律效力的文件,不能用于在中国境内的 申报、备案、运输或流通。

中国市场的安全数据表须按 GB/T 16483GB/T 17519 另行编制, 这不在本次交付范围内。贵公司在中国境内的合规文件,仍由贵公司自行负责。

我们是做网店的公司,不是化工公司。
不买货、不存货、不发货、不碰贵公司的客户、不从货款抽成。 货、客户、价格、订单、收款、发货 —— 全部在贵公司手里。
← 返回贵公司的全部产品

Гидролизованный говяжий коллаген. CAS 9007-34-5.

We are not issuing this sheet yet.

Our engine could not build a document for this substance that meets our own completeness threshold, so it is held for review rather than published. We would rather tell you that than sell you a sheet we do not stand behind.

Leave your details and we will tell you when it is ready, or what we can issue in the meantime.

Get the full details for CAS 9007-34-5

Sixteen sections in the structure of REACH Annex II, the harmonised classification, and the source behind every value — issued in one language you choose.

A sheet that fails inspection stops the shipment, not the paperwork.

Tell us where to send it. We reply within one working day.

We reply within one working day.

Working draft €49.99 · expert-reviewed €249.99, per substance.

What is in the buyer pack

Everything your compliance officer will ask for, in one file.

  • The product page as PDF — the record as published, so what you forward matches what you read.
  • The safety data sheet at your entitlement level — sixteen sections in the order set by REACH Annex II, for this substance, in the language you select.
  • The CLP label artwork — generated from the same classification as the sheet, so the two cannot disagree.
  • The specification, and the certificate of analysis where batch data exists.
  • sources.txt — every citation with the date it was read.
  • An explicit list of what we could not establish — fields marked unavailable rather than filled with an estimate. This is the honest part of the document and we do not hide it in a footnote.

Your European buyer is going to forward this to somebody who was not on the call. The pack exists so that what they forward is complete, self-explanatory and traceable — rather than four attachments and a sentence beginning “I think this is everything”.

These switch the language of this page. Single substances. Mixtures on enquiry. One document, one language — additional languages are priced separately. Every version, including the Chinese one, is written to EU law — (EC) No 1907/2006 (REACH) Annex II and (EU) 2020/878 — and translated from it. The Chinese version is a reference translation, not a legally valid document for the Chinese market: an SDS for China must be compiled separately to GB/T 16483 and GB/T 17519.

Dane transkrybowane z rejestrów regulacyjnych i literatury fachowej, z podaniem źródła i wydania. Nie zastępują karty charakterystyki dostawcy. Pola bez zapisanego źródła oznaczone jako takie.

Przegląd chemiczny: CAS 9007-34-5 — Uts Shanghai
CAS 9007-34-5 — Uts Shanghai — Karta substancji jest przygotowywana. Odśwież stronę za kilka minut.

BADANIA NAUKOWE

[1]PubMed2026
Haykal D. (2026). "Skin Glycomics: Unmasking the Role of Glycation End Products in Cutaneous Aging and Dermatology.". Journal of cosmetic dermatology. https://doi.org/10.1111/jocd.70937
[2]PubMed2026
Shen R, Xu R, Lei H et al.. (2026). "Platelet-Collagen Interactions in Hemostatic Mechanisms.". Advanced healthcare materials. https://doi.org/10.1002/adhm.71326
[3]PubMed2026
Ning R, Fu X, Chen L et al.. (2026). "Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics.". Progress in retinal and eye research. https://doi.org/10.1016/j.preteyeres.2026.10148
[4]PubMed2026
Yip T, Stockis J, Simpson C et al.. (2026). "ILC2s regulate a fibroblast progenitor niche in the pancreas.". Science (New York, N.Y.). https://doi.org/10.1126/science.aea5113
[5]PubMed2026
Lee JH, Hwang IY, Jang HJ et al.. (2026). "Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke.". Cell metabolism. https://do
[6]PubMed2026
Pasquier N, Pelkonen M, Carraz-Billat E et al.. (2026). "Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.". Nature communications. htt
[7]PubMed2026
Guan Z, Li W, Liu S et al.. (2026). "Drp1-driven fragmentation of scleral mitochondria promotes myopia development.". Proceedings of the National Academy of Sciences of the United States of America. h
[8]PubMed2026
Zhu J, Sun D, Zeng G et al.. (2026). "Histaminylation alters collagen matrix mechanics and attenuates cardiac fibrosis post-myocardial infarction via mechanotransduction signaling axis.". Signal trans
📚 Naukowe referencje (Chicago Author-Date) 18 refs · 3 baz

MOLECULE Bibliografia per-CAS (live z 13+ baz)

Źródła: db:pubmed (15) · db:core (1) · db:crossref (3)

  1. db:pubmed Shen R, Xu R, Lei H et al.. (2026). "Platelet-Collagen Interactions in Hemostatic Mechanisms.". Advanced healthcare materials. https://doi.org/10.1002/adhm.71326
  2. db:pubmed Ning R, Fu X, Chen L et al.. (2026). "Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics.". Progress in retinal and eye research. https://doi.org/10.1016/j.preteyeres.2026.101489
  3. db:pubmed Yip T, Stockis J, Simpson C et al.. (2026). "ILC2s regulate a fibroblast progenitor niche in the pancreas.". Science (New York, N.Y.). https://doi.org/10.1126/science.aea5113
  4. db:pubmed Lee JH, Hwang IY, Jang HJ et al.. (2026). "Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke.". Cell metabolism. https://doi.org/10.1016/j.cmet.2026.04.001
  5. db:pubmed Pasquier N, Pelkonen M, Carraz-Billat E et al.. (2026). "Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.". Nature communications. https://doi.org/10.1038/s41467-026-75127-0
  6. db:pubmed Guan Z, Li W, Liu S et al.. (2026). "Drp1-driven fragmentation of scleral mitochondria promotes myopia development.". Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2511427123
  7. db:pubmed Zhu J, Sun D, Zeng G et al.. (2026). "Histaminylation alters collagen matrix mechanics and attenuates cardiac fibrosis post-myocardial infarction via mechanotransduction signaling axis.". Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-02721-5
  8. db:pubmed Hirata T, Choudhary D, Nguyen Q et al.. (2026). "Site-specific glycosylation of Sec24D and myoferlin recruit ERGIC to ER exit sites for collagen trafficking.". Nature communications. https://doi.org/10.1038/s41467-026-73027-x
  9. db:pubmed Wan R, Deng Y, Hu Z et al.. (2026). "Multi-Omics Profiling Reveals Immunomodulatory and Pro-Regenerative Effects of a Graphene Oxide-Collagen Scaffold in Massive Rotator Cuff Tears.". Advanced science (Weinheim, Baden-Wurttemberg, Germany). https://doi.org/10.1002/advs.202523821
  10. db:pubmed Wojcik G, Sahu-Osen A, Waked P et al.. (2026). "Enhanced fatty acid availability rewires fibroblasts metabolism and decreases collagen deposition in lung fibrosis.". Cellular and molecular life sciences : CMLS. https://doi.org/10.1007/s00018-026-06256-4
  11. db:pubmed Li J, Feng J, Han Y et al.. (2026). "Impaired P4HA1-Driven Hydroxyproline Formation Mediates Scleral Collagen Disruption in Form-Deprivation Myopia.". Investigative ophthalmology & visual science. https://doi.org/10.1167/iovs.67.5.60
  12. db:pubmed Cui H, Hu H, He X et al.. (2026). "Dermal fibroblast-targeted trans-amplifying RNA nanotherapeutics for skin extracellular matrix regeneration.". Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.114947
  13. db:pubmed Elblová P, Calé A, Andělová H et al.. (2026). "KEAP1-mediated mitochondrial remodeling on stiffness-graded collagen substrates drives hepatocellular carcinoma adaptation.". Biomaterials. https://doi.org/10.1016/j.biomaterials.2026.124302
  14. db:pubmed Sinha M, Chugh A. (2026). "Design and In Vitro Application of Bioactive Cell-Penetrating Peptides as Effective Therapeutic Agents for Corneal Wound Healing.". Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00183
  15. db:core ปีที่ 34 ฉบับที่ 4 2567, ปกวารสารวิชาการพระจอมเกล้าพระนครเหนือ. (2024). "ปกวารสารวิชาการพระจอมเกล้าพระนครเหนือ ปีที่ 34 ฉบับที่ 4 2567". The Journal of King Mongkut's University of Technology North Bangkok.
  16. db:crossref (2017). "Table of Contents". Nutrition. https://doi.org/10.1016/s0899-9007(16)30272-6
  17. db:crossref (2010). "Posters". Vox Sanguinis. https://doi.org/10.1111/j.1423-0410.2010.01400.x
  18. db:crossref (1978). "Announcement". Vox Sanguinis. https://doi.org/10.1159/000467599
Status regulacyjny substancji
Brak wpisów dla tego CAS w sprawdzonych wykazach ograniczeń (lista kandydacka SVHC, REACH Załącznik XVII; zbiory niepełne - nie jest to potwierdzenie zgodności). Klasyfikacja CLP i status transportowy (ADR): patrz sekcja GHS oraz karta charakterystyki (SDS).
🧪 Dane chemiczne
Numer CAS
9007-34-5
🔍 Identyfikatory zewnętrzne
3 z 16 systemów ID19%
BazaIdentyfikatorAkcje
CAS Registry Number9007-34-5Otwórz →
MeSH UID (NLM)D003094Otwórz →
WikiData QIDQ26868Otwórz →

Źródła: PubChem (NIH), Wikidata SPARQL, KEGG, ChEMBL (EBI), CompTox CTX (EPA).

Why this page can be checked

Identity

CAS, EC and molecular formula, resolved across the identifier systems a buyer uses. The count of systems resolved is shown, so you can see how well characterised this substance is rather than assuming.

Data

Every physicochemical value carries the source it came from and the date that source was read. Open any of them.

Classification

Read against the harmonised entry where one exists, with the index number stated. Self-classification is shown separately and labelled.

Regulatory

Inventory, restriction, authorisation and candidate-list status, each stated individually. Where a status is not established, this page says so — it never says no restrictions apply.

Documentation

Which documents exist, at what review level, in which languages, and when each was issued.

Supplier

Who is selling this, and what they have published about themselves.

Nothing on this page is a certification. It is a record you can audit.

Two guarantees, both with their limits stated

The Gap Report Guarantee

If the available evidence cannot support a defensible document for your CAS number and product specification, we will not invent the missing values. You receive a documented gap report and choose: a refund, store credit, or the report on its own.

A visible gap is worth more than a plausible number, because the plausible number is the one that fails when somebody checks it.

The Re-issue Promise

If a signed card is rejected by an authority or by a customer’s compliance officer on one of the points we checked and reported as passed, we re-issue it corrected at no charge and credit the original fee.

This covers the checks we performed and named. It does not cover registration status, tonnage, or your role in the supply chain — those are not ours to hold, and a guarantee that pretended otherwise would be worth nothing.

Гидролизованный говяжий коллаген — CAS 9007-34-5. Listed by Uts Shanghai. Prepared from the supplier’s public catalogue; not verified against their internal data.

Dane z PubChemŹródło: PubChem (NIH)